NASDAQ:TRNX - Taronis Technologies Stock Price, News, & Analysis

$0.31
-0.01 (-3.08 %)
(As of 07/22/2019 08:30 AM ET)
Today's Range
$0.2560
Now: $0.3146
$0.34
50-Day Range
$0.13
MA: $0.29
$0.46
52-Week Range
$0.13
Now: $0.3146
$13.60
Volume23.05 million shs
Average Volume32.69 million shs
Market Capitalization$9.57 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.93

Industry, Sector and Symbol

Industry Special industry machinery, not elsewhere classified
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:TRNX
CUSIPN/A
CIKN/A
Phone727-934-3448

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.71 million
Book Value$2.99 per share

Profitability

Net Income$-15,040,000.00
Net Margins-135.02%

Miscellaneous

EmployeesN/A
Market Cap$9.57 million
Next Earnings Date8/13/2019 (Estimated)
OptionableNot Optionable

Receive TRNX News and Ratings via Email

Sign-up to receive the latest news and ratings for TRNX and its competitors with MarketBeat's FREE daily newsletter.

Taronis Technologies (NASDAQ:TRNX) Frequently Asked Questions

What is Taronis Technologies' stock symbol?

Taronis Technologies trades on the NASDAQ under the ticker symbol "TRNX."

How were Taronis Technologies' earnings last quarter?

Taronis Technologies Inc (NASDAQ:TRNX) released its quarterly earnings results on Monday, May, 20th. The company reported ($0.60) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.11) by $0.49. The business had revenue of $4.91 million for the quarter, compared to analyst estimates of $4.15 million. Taronis Technologies had a negative net margin of 135.02% and a negative return on equity of 81.90%. View Taronis Technologies' Earnings History.

When is Taronis Technologies' next earnings date?

Taronis Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, August 13th 2019. View Earnings Estimates for Taronis Technologies.

What is the consensus analysts' recommendation for Taronis Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Taronis Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Taronis Technologies.

Has Taronis Technologies been receiving favorable news coverage?

News articles about TRNX stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Taronis Technologies earned a news impact score of 0.9 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Taronis Technologies.

Are investors shorting Taronis Technologies?

Taronis Technologies saw a increase in short interest during the month of June. As of June 30th, there was short interest totalling 1,655,400 shares, an increase of 29.2% from the May 30th total of 1,280,900 shares. Based on an average daily volume of 6,590,000 shares, the short-interest ratio is currently 0.3 days. Currently, 8.2% of the company's stock are short sold. View Taronis Technologies' Current Options Chain.

Who are some of Taronis Technologies' key competitors?

What other stocks do shareholders of Taronis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Taronis Technologies investors own include Novavax (NVAX), Hemispherx BioPharma (HEB), Adomani (ADOM), Biocept (BIOC), BioPharmX (BPMX), Catalyst Pharmaceuticals (CPRX), FuelCell Energy (FCEL), Aevi Genomic Medicine (GNMX), Histogenics (HSGX) and Jaguar Health (JAGX).

How do I buy shares of Taronis Technologies?

Shares of TRNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Taronis Technologies' stock price today?

One share of TRNX stock can currently be purchased for approximately $0.3146.

How big of a company is Taronis Technologies?

Taronis Technologies has a market capitalization of $9.57 million and generates $9.71 million in revenue each year. View Additional Information About Taronis Technologies.

What is Taronis Technologies' official website?

The official website for Taronis Technologies is http://www.magnegas.com/.

How can I contact Taronis Technologies?

Taronis Technologies' mailing address is 300 W. CLARENDON AVENUE SUITE 230, PHOENIX AZ, 85013. The company can be reached via phone at 727-934-3448 or via email at [email protected]


MarketBeat Community Rating for Taronis Technologies (NASDAQ TRNX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  51
MarketBeat's community ratings are surveys of what our community members think about Taronis Technologies and other stocks. Vote "Outperform" if you believe TRNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Featured Article: Liquidity

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel